Related Experiment Video
Updated: Aug 20, 2025

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
KDM6B regulates M2 polarization of macrophages by modulating the stability of nuclear β-catenin
Lingfang Du1, Bo Dai2, Xuan Liu2
1School of Medicine, Nankai University, Tianjin 300071, China; Clinical Medical Research Center, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Abstract:
Accumulating evidences suggest that the epigenetic regulation plays a pivotal role in establishing phenotype and function of tumor associated macrophages (TAMs). KDM6B is an epigenetic enzyme responsible for the H3K27me3 and reported to influence macrophage polarization. However, the underlying mechanism remains to be determined. Here, we demonstrated that inhibition of KDM6B in TAMs increased M2 polarization induced by coculture of breast cancer cells. Furthermore, we identified that KDM6B downregulation activated β-catenin/c-Myc signaling, and thus promoted the M2-like phenotype. KDM6B accelerated the intranuclear ubiquitination degradation of β-catenin, which depended on its demethylase activity. Therapeutically, our data showed that activated vitamin D analog paricalcitol upregulated the expression of KDM6B and decreased the M2 polarization, consequently protected against tumor progress in the xenograft mouse model of breast cancer. Taken together, our data reveal that epigenetic regulator KDM6B prevents M2 polarization via promoting the intranuclear degradation of β-catenin. Active vitamin D analog induces KDM6B and suppresses tumor progress, suggesting a novel therapeutic potential of epigenetic modulation for the tumor treatment.
Insights
Epigenetic regulator KDM6B prevents M2 polarization by degrading beta-catenin. Vitamin D analogs upregulate KDM6B, suppressing tumor progression and offering novel epigenetic therapy potential for cancer.
Area of Science:
- Epigenetics
- Cancer Biology
- Immunology
Background:
- Epigenetic regulation influences tumor-associated macrophage (TAM) phenotype and function.
- KDM6B, an epigenetic enzyme, affects macrophage polarization, but its mechanism in TAMs is unclear.
Purpose of the Study:
- To elucidate the mechanism by which KDM6B regulates macrophage polarization in breast cancer.
- To investigate the therapeutic potential of targeting KDM6B in a breast cancer model.
Main Methods:
- Co-culture of breast cancer cells with TAMs to induce M2 polarization.
- Inhibition and assessment of KDM6B activity.
- Analysis of beta-catenin/c-Myc signaling pathway.
- Xenograft mouse model of breast cancer treated with paricalcitol.
Main Results:
- KDM6B inhibition increased M2 polarization in TAMs.
- KDM6B downregulation activated beta-catenin/c-Myc signaling, promoting M2-like phenotype.
- KDM6B's demethylase activity promoted intranuclear degradation of beta-catenin.
- Paricalcitol (an activated vitamin D analog) upregulated KDM6B, decreased M2 polarization, and inhibited tumor growth in vivo.
Conclusions:
- KDM6B epigenetically suppresses M2 polarization by enhancing beta-catenin degradation.
- Activated vitamin D analogs represent a potential epigenetic therapy for cancer by modulating KDM6B and suppressing tumor progression.
More Related Videos
08:37Polarization and Characterization of M1 and M2 Human Monocyte-Derived Macrophages on Implant Surfaces
Published on: December 6, 2024
07:45Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis
Published on: November 28, 2015
Related Concept Videos
Master Transcription Regulators
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Abnormal Proliferation
Canonical Wnt Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...